| |
|
|
|
Corbus Pharmaceuticals Holdings Inc.  
|
|
5.3 -0.3 (-0.05%) |
08-23 16:00 |
|
Open: |
5.59 |
Pre close: |
5.6 |
Target:
|
7.01 
|
|
High: |
5.635 |
Low: |
5.29 |
Resistance:
|
6.00
6.45
|
|
Volume: |
677,475 |
Market Cap: |
343M |
Support:
|
5.29
4.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.61
|
MACD |
MACD(12,26):
|
-0.20 |
|
MA(20): |
5.76 |
Signal(12,26,9): |
-0.20 |
|
MA(100): |
6.73 |
Stochastic Oscillator |
%K(14,3):
|
19.36 |
|
MA(250): |
6.79  |
%D(3): |
26.05 |
|
Average Volume(K) |
3-Month: |
67915
|
52-Week |
High:
|
9.11 |
|
10-Days: |
73939 |
Low: |
4.80 |
|
RSI |
RSI(14):
|
34.14 |
Change(%): |
6.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.930 |
Return on Equity (ttm) |
-108.9 |
Shares Out. (M) |
55.60 |
|
EPS Est. Current Year |
-0.640 |
Return on Assets (ttm) |
-46.4 |
Shares Float (M) |
56.11 |
|
EPS Est. Next Year |
-0.680 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.45 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
3308.3 |
% Held by Institutions |
44.44 |
|
Forward EPS |
-1.060 |
Gross Profit (p.s.) |
-0.788 |
Shares Short (K) |
16290 |
|
Book Value (p.s.) |
0.730 |
EBITDA (p.s.) |
-1.020 |
P/E |
-5.70 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.26 |
|
Profit Margin |
-164.68 |
Operating Cash Flow
(M) |
-28.98 |
P/S |
526214304.00 |
|
Operating Margin |
-168.56 |
Levered Free Cash Flow
(M) |
-9.49 |
P/CF |
-10.17 |
|
|
|
|
|
|
